Exchange: NASDAQ·Updated 07:30 PM EST
TVRD logo

TVRD Tvardi Therapeutics, Inc.

$0.9653
$0.0432
(4.57%)
Today
Closed $0.9893
$0.024
(2.43%)
After Hours
Reported EarningsNov 13
Mkt Cap$13.22M
Vol161,559.00

About TVRD

Tvardi Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases with significant unmet need. The company was founded in 2017 and is headquartered in Sugar Land, TX.
37

Bearish Sentiment

How do you feel about TVRD?

Xpotrad
$TVRD something is up and going on here, since this stock has not had this kind of positive upside volume and move up like today for many months now, with just about all of the past buyers back from July all stopped out months ago, i would think the buy side buy interest coming from some place other than past investors, perhaps the usual insider leak of something positive.
4

Advertisement|Remove ads.